INDGNHealthcare Research, Analytics & Technology
Indegene Ltd — Cash Flow Statement
₹434.60
-1.77%
Indegene Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Net Long Term Debt Issuance | -403.10 Cr | -6.70 Cr | 376.10 Cr | -6.53 Cr | — |
| Long Term Debt Payments | -403.10 Cr | -6.70 Cr | -18.20 Cr | -51.13 Cr | — |
| Investing Cash Flow | -682.70 Cr | -327.20 Cr | -893.30 Cr | -160.21 Cr | — |
| Interest Received Cfi | 48.60 Cr | 26.10 Cr | 6.60 Cr | 0.31 Cr | — |
| Net Investment Purchase And Sale | -590.00 Cr | -170.50 Cr | -488.60 Cr | -119.39 Cr | — |
| Sale Of Investment | 6.48K Cr | 1.53K Cr | 11.00 Cr | 266.36 Cr | — |
| Purchase Of Investment | -7.07K Cr | -1.70K Cr | -499.60 Cr | -385.74 Cr | — |
| Net Business Purchase And Sale | -111.30 Cr | -172.10 Cr | -392.50 Cr | -16.42 Cr | — |
| Purchase Of Business | -111.30 Cr | -172.10 Cr | -392.50 Cr | -16.42 Cr | — |
| Net PPE Purchase And Sale | -30.00 Cr | -10.70 Cr | -18.80 Cr | -24.71 Cr | — |
| Purchase Of PPE | -30.00 Cr | -10.70 Cr | -18.80 Cr | -24.71 Cr | — |
| Operating Cash Flow | 441.90 Cr | 507.70 Cr | 130.20 Cr | 297.04 Cr | — |
| Taxes Refund Paid | -160.00 Cr | -124.90 Cr | -108.20 Cr | -70.35 Cr | — |
| Change In Working Capital | 24.10 Cr | 95.80 Cr | -216.00 Cr | 53.82 Cr | — |
| Change In Other Current Liabilities | 61.10 Cr | 74.20 Cr | -17.70 Cr | 220.79 Cr | — |
| Change In Receivables | -47.70 Cr | 1.10 Cr | -174.60 Cr | -166.97 Cr | — |
| Other Non Cash Items | -46.90 Cr | -82.00 Cr | 13.00 Cr | 50.77 Cr | — |
| Stock Based Compensation | 17.40 Cr | 21.30 Cr | 15.80 Cr | 7.54 Cr | — |
| Provisionand Write Offof Assets | 15.30 Cr | -5.40 Cr | -0.20 Cr | 2.16 Cr | — |
| Depreciation And Amortization | 80.20 Cr | 76.10 Cr | 59.80 Cr | 33.45 Cr | — |
| Depreciation | 80.20 Cr | 76.10 Cr | 59.80 Cr | 33.45 Cr | — |
| Gain Loss On Investment Securities | -29.20 Cr | -16.50 Cr | -6.90 Cr | -5.01 Cr | — |
| Net Foreign Currency Exchange Gain Loss | 1.70 Cr | -6.40 Cr | 9.90 Cr | -2.34 Cr | — |
| Net Income From Continuing Operations | 539.30 Cr | 458.60 Cr | 363.00 Cr | 226.50 Cr | — |
| Free Cash Flow | 411.90 Cr | 497.00 Cr | 111.40 Cr | 272.33 Cr | — |
| Repayment Of Debt | -403.10 Cr | -6.70 Cr | -18.20 Cr | -51.13 Cr | — |
| Issuance Of Capital Stock | 732.70 Cr | 0.00 | 0.00 | 262.90 Cr | — |
| Capital Expenditure | -30.00 Cr | -10.70 Cr | -18.80 Cr | -24.71 Cr | — |
| End Cash Position | 241.00 Cr | 188.60 Cr | 73.60 Cr | 506.28 Cr | — |
| Beginning Cash Position | 188.60 Cr | 73.60 Cr | 506.30 Cr | 133.36 Cr | — |
| Effect Of Exchange Rate Changes | 5.70 Cr | 0.70 Cr | -2.70 Cr | 2.60 Cr | — |
| Changes In Cash | 46.70 Cr | 114.30 Cr | -430.00 Cr | 370.31 Cr | — |
| Financing Cash Flow | 287.50 Cr | -66.20 Cr | 333.10 Cr | 233.48 Cr | — |
| Interest Paid Cff | -10.30 Cr | -31.60 Cr | -17.60 Cr | -2.73 Cr | — |
| Net Common Stock Issuance | 732.70 Cr | 0.00 | 0.00 | 261.89 Cr | — |
| Common Stock Issuance | 732.70 Cr | 0.00 | 0.00 | 262.90 Cr | — |
| Net Issuance Payments Of Debt | -403.10 Cr | -6.70 Cr | 376.10 Cr | -6.53 Cr | — |
| Long Term Debt Issuance | — | 0.00 | 394.30 Cr | 44.60 Cr | 0.00 |
| Issuance Of Debt | — | 0.00 | 394.30 Cr | 44.60 Cr | 0.00 |
| Repurchase Of Capital Stock | — | — | 0.00 | -1.01 Cr | -1.56 Cr |
| Common Stock Payments | — | — | 0.00 | -1.01 Cr | -1.56 Cr |
| Other Cash Adjustment Outside Changein Cash | — | — | — | — | -54.35 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Indegene Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.